Fusion Antibodies PLC (FAB) — Financial Flexibility Index
Fusion Antibodies PLC (FAB) has a Financial Flexibility Index of -0.47x as of September 2025. Free cash flow of GBX-515.00K (operating CF GBX-575.00K minus capex GBX60.00K) represents 0% of total liabilities (GBX1.09 Million). Check Fusion Antibodies PLC (FAB) strategic asset index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Fusion Antibodies PLC Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for Fusion Antibodies PLC across 11 annual periods. See Fusion Antibodies PLC (FAB) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Fusion Antibodies PLC (2015–2025)
Year-by-year free cash flow to debt coverage for Fusion Antibodies PLC. For the full company profile including market capitalisation, see Fusion Antibodies PLC stock valuation.
| Year | Flexibility Index | Free Cash Flow (GBX) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.07x | GBX-1.35 Million | GBX-1.36 Million | GBX654.00K | ▲ +26.5% |
| 2024 | -2.82x | GBX-1.77 Million | GBX-1.77 Million | GBX627.00K | ▼ -61.3% |
| 2023 | -1.75x | GBX-1.64 Million | GBX-1.75 Million | GBX939.00K | ▼ -2887.9% |
| 2022 | -0.06x | GBX-72.00K | GBX-330.00K | GBX1.23 Million | ▲ +91.9% |
| 2021 | -0.73x | GBX-786.00K | GBX-1.15 Million | GBX1.08 Million | ▼ -1463.6% |
| 2020 | -0.05x | GBX-57.00K | GBX-166.00K | GBX1.23 Million | ▼ -114.6% |
| 2019 | 0.32x | GBX282.23K | GBX-1.10 Million | GBX888.53K | ▼ -61.4% |
| 2018 | 0.82x | GBX521.79K | GBX77.19K | GBX633.59K | ▲ +600.9% |
| 2017 | 0.12x | GBX52.90K | GBX-37.37K | GBX450.22K | ▼ -87.4% |
| 2016 | 0.93x | GBX382.33K | GBX346.57K | GBX411.43K | ▲ +209.7% |
| 2015 | -0.85x | GBX-170.85K | GBX-182.05K | GBX201.67K | — |